Compare Enveric Biosciences Inc (ENVB) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Enveric Biosciences Inc trades at $1.51 (market cap $6.69M), while T-Rex 2X Long MSTR Daily Target ETF trades at $40.1 (market cap $930.31M). The key difference: T-Rex 2X Long MSTR Daily Target ETF is far larger — about 139.1× Enveric Biosciences Inc's market cap, and Enveric Biosciences Inc is more actively traded (41,141 versus 4,612,204). Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and T-Rex 2X Long MSTR Daily Target ETF for 18 Days on average.
| ENVB | MSTU | |
|---|---|---|
Market Cap | $6.69M | $930.31M |
Volume | 41,141 | 4,612,204 |
Sector | Health | Leveraged / Inverse |
52-Week High | $10.80 | $451.00 |
52-Week Low | $1.27 | $14.60 |
Typical Hold Time | 14 Days | 18 Days |
Enterprise Value | -$1.60M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.495, up 1.7% on the day, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The company reported no revenue in 2025 and a net loss of $8.77 million, though it has consistently beaten EPS expectations. Recent news includes a new U.S. patent allowance for its non-hallucinogenic mescaline derivatives and participation in an investment conference.
The outlook remains speculative given the lack of revenue and negative profitability, but analyst consensus is bullish with 75% buy ratings. Key risks include the pre-revenue biotech model and dependence on successful drug development. Upside potential hinges on clinical progress and regulatory milestones for its psychiatric therapeutics pipeline.
MSTU shares declined significantly, dropping 13.68% to $39.45 amid bearish technical signals and leveraged ETF volatility. The stock faces pressure from its reverse stock split implementation and weak technical positioning below key resistance levels. Recent trading activity shows heavy volume as investors navigate the leveraged ETF structure that amplifies underlying MicroStrategy stock movements.
The outlook remains challenging with technical indicators signaling bearish momentum and the leveraged ETF structure creating additional volatility risks. Investors face compounded daily value erosion while the fund's performance depends heavily on MicroStrategy's Bitcoin exposure and market sentiment toward cryptocurrency-linked equities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
